A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(34 sites)

United States

Mayo Clinic in Arizona - Phoenix- Site Number : 8400058, Phoenix, Arizona

Los Angeles Hematology Oncology Medical Group- Site Number : 8400027, Los Angeles, California

Private Practice - Dr. James R. Berenson- Site Number : 8400044, West Hollywood, California

Smilow Cancer Center at Yale-New Haven- Site Number : 8400020, New Haven, Connecticut

Maryland Oncology Hematology- Site Number : 8400038, Washington D.C., District of Columbia

Life Clinical Trials - Coral Springs- Site Number : 8400055, Coral Springs, Florida

Center for Rheumatology, Immunology and Arthritis- Site Number : 8400031, Fort Lauderdale, Florida

Mayo Clinic in Florida- Site Number : 8400002, Jacksonville, Florida

The Oncology Institute of Hope & Innovation - Lakeland- Site Number : 8400054, Lakeland, Florida

D&H Pompano Research Center- Site Number : 8400049, Margate, Florida

Millennium Oncology - Pembroke Pines- Site Number : 8400011, Pembroke Pines, Florida

BRCR Global- Site Number : 8400008, Plantation, Florida